Story · Health Tech
Abbott’s UltiSynq defibrillation lead lands simultaneous US-EU approvals
1 outlet · first reported by Medical Device Network on
The US and EU approvals for Abbott’s UltiSynq defibrillation lead were supported by results from the ASCEND CSP trial. (Medical Device Network)
Coverage, in order
-
Abbott’s UltiSynq defibrillation lead lands simultaneous US-EU approvalsThe US and EU approvals for Abbott’s UltiSynq defibrillation lead were supported by results from the ASCEND CSP trial.
Alivewire groups outlets reporting the same story. Each headline links to the outlet that wrote it; nothing is republished here.